Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review
作者： Bruno Silva Andrade , Fernanda de Souza Rangel , Naiane Oliveira Santos , Andria dos Santos Freitas , Wagner Rodrigues de Assis Soares
DOI: 10.3389/FPHAR.2020.590598
关键词:
摘要: The SARS-CoV-2 outbreak originally appeared in China in December 2019 and became a global pandemic in March 2020. This infectious disease has directly affected public health …
frontiersin.org
sci-hub.st 参考文章(139)
Christian Shema Mugisha, Hung R. Vuong, Maritza Puray-Chavez, Adam L. Bailey, Julie M. Fox, Rita E. Chen, Alex W. Wessel, Jason M. Scott, Houda H. Harastani, Adrianus C. M. Boon, Haina Shin, Sebla B. Kutluay, A Simplified Quantitative Real-Time PCR Assay for Monitoring SARS-CoV-2 Growth in Cell Culture. mSphere. ,vol. 5, ,(2020) , 10.1128/MSPHERE.00658-20
Maren de Vries, Adil S Mohamed, Rachel A Prescott, Ana M Valero-Jimenez, Ludovic Desvignes, Rebecca O’Connor, Claire Steppan, Annaliesa S. Anderson, Joseph Binder, Meike Dittmann, Comparative study of a 3CL pro inhibitor and remdesivir against both major SARS-CoV-2 clades in human airway models. bioRxiv. ,(2020) , 10.1101/2020.08.28.272880
Chong Yu, Zhiguo Zhang, Yujiao Guo, Jing Shi, Guangchang Pei, Wenhui Liao, Ying Yao, Rui Zeng, Lopinavir/ritonavir is associated with pneumonia resolution in COVID-19 patients with influenza coinfection：a retrospective matched-pair cohort study Authorea Preprints. ,(2020) , 10.22541/AU.159040088.84670621
David A. Jans, Kylie M. Wagstaff, Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal? Cells. ,vol. 9, pp. 2100- ,(2020) , 10.3390/CELLS9092100
Robert L. Hoffman, Robert S. Kania, Mary A. Brothers, Jay F. Davies, Rose A. Ferre, Ketan S. Gajiwala, Mingying He, Robert J. Hogan, Kirk Kozminski, Lilian Y. Li, Jonathan W. Lockner, Jihong Lou, Michelle T. Marra, Lennert J. Mitchell, Brion W. Murray, James A. Nieman, Stephen Noell, Simon P. Planken, Thomas Rowe, Kevin Ryan, George J. Smith, James E. Solowiej, Claire M. Steppan, Barbara Taggart, Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19. Journal of Medicinal Chemistry. ,vol. 63, pp. 12725- 12747 ,(2020) , 10.1021/ACS.JMEDCHEM.0C01063
Peter W Horby, Marion Mafham, Jennifer L Bell, Louise Linsell, Natalie Staplin, Jonathan Emberson, Adrian Palfreeman, Jason Raw, Einas Elmahi, Benjamin Prudon, Christopher Green, Simon Carley, David Chadwick, Matthew Davies, Matthew P Wise, J Kenneth Baillie, Lucy C Chappell, Saul N Faust, Thomas Jaki, Katie Jefferey, Wei Shen Lim, Alan Montgomery, Kathryn Rowan, Edmund Juszczak, Richard Haynes, Martin J Landray, None, Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial The Lancet. ,vol. 396, pp. 1345- 1352 ,(2020) , 10.1016/S0140-6736(20)32013-4
RECOVERY Collaborative Group, None, Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19 The New England Journal of Medicine. ,vol. 383, pp. 2030- 2040 ,(2020) , 10.1056/NEJMOA2022926
Saptarshi Chatterjee, Remdesivir: Critical Clinical Appraisal for COVID 19 Treatment. Drug Research. ,vol. 71, pp. 138- 148 ,(2021) , 10.1055/A-1288-4078
WHO Solidarity Trial Consortium, None, Repurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results. The New England Journal of Medicine. ,vol. 384, pp. 497- 511 ,(2020) , 10.1056/NEJMOA2023184
Sergei Koralov, Kelly Ruggles, Ludovic Desvignes, Annaliesa Anderson, Maren de Vries, Adil Mohamed, Joseph Binder, Claire Steppan, Rebecca O'Connor, Alberto Herrera, Joseph Cooper Devlin, Meike Dittmann, Ana Valero-Jimenez, Austin Schinlever, Rachel Anne Prescott, Ellie Ivanova, Paige Loose, A comparative analysis of SARS-CoV-2 antivirals in human airway models characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19 bioRxiv. ,(2021) , 10.1101/2020.08.28.272880